Nitrogen cycle

Global Inhaled Nitric Oxide Markets, 2020-2027 - Ongoing R&D Activities Leading to New Application Areas in the Healthcare Industry

Retrieved on: 
金曜日, 3月 26, 2021
Chemistry, Physical sciences, Chemical compounds, Oxides, Gaseous signaling molecules, Nitrogen cycle, GABAA receptor positive allosteric modulators, NMDA receptor antagonists, Nitric oxide, Lead(II,IV) oxide, Biological functions of nitric oxide

The global inhaled nitric oxide market was valued at $634.4 million in 2019 and is estimated to reach $1,180.98 million by 2027, registering a CAGR of 8.1% from 2020-2027.

Key Points: 
  • The global inhaled nitric oxide market was valued at $634.4 million in 2019 and is estimated to reach $1,180.98 million by 2027, registering a CAGR of 8.1% from 2020-2027.
  • Nitric oxide (iNO) is selective pulmonary vasodilation and is delivered to the patient via mechanical ventilation after dilution with an oxygen/air mixture nitric oxide delivery system.
  • Further, clinical trials evaluating the use of inhaled nitric oxide for numerous indications are ongoing.
  • Conversely, ongoing R&D activities leading to new application areas in the healthcare industry are expected to provide lucrative opportunities for the expansion of the global market in the near future.

Claritas Announces Addition of Perenlei Enkhbaatar, M.D., Ph.D., FAHA to the Company’s Board of Directors

Retrieved on: 
金曜日, 3月 26, 2021
Branches of biology, Chemistry, Physical sciences, Oxides, Gaseous signaling molecules, Nitrogen cycle, Nitric oxide, Nitric oxide

The addition of Dr. Enkhbaatar to the Companys Board enhances and strengthens our focus on nitric oxide pharmaceuticals, stated Robert Farrell, President and CEO.

Key Points: 
  • The addition of Dr. Enkhbaatar to the Companys Board enhances and strengthens our focus on nitric oxide pharmaceuticals, stated Robert Farrell, President and CEO.
  • We previously announced the addition of Dr. Salvatore Cuzzocrea to our Board.
  • Both Dr. Enkhbaatar and Dr. Cuzzocrea are internationally renowned authorities and leaders on the biology and pathophysiology of nitric oxide.
  • Dr. Enkhbaatar will be a strong strategic resource for Claritas, and we look forward to the contributions he will make.

Worldwide Industry for Animal Feed: 2021 Market Study - Impact Analysis of COVID-19

Retrieved on: 
金曜日, 3月 19, 2021
Amino acid, Nitrogen cycle, Zwitterions, Animal feed, Ingredient, Agriculture

DUBLIN, March 19, 2021 /PRNewswire/ -- The "Global Animal Feed Ingredient Market Powered by Antibiotic Alternatives and Vertical Integration" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, March 19, 2021 /PRNewswire/ -- The "Global Animal Feed Ingredient Market Powered by Antibiotic Alternatives and Vertical Integration" report has been added to ResearchAndMarkets.com's offering.
  • Animal feed ingredients are micro-ingredients that improve the feed conversion ratio and overall animal performance.
  • Though market growth is expected to recover in 2021 because of the vaccine, the impact of the COVID-19 pandemic on the animal feed ingredient market is expected to be most intense in developing economies because of low purchasing power.
  • Impact of COVID-19 on the Value Chain, Animal Nutrition Industry
    Unit Shipment Forecast by Product, Animal Feed Ingredient Market
    Revenue Forecast by End-Use Industry, Animal Feed Ingredient Market
    Unit Shipment Forecast by End-Use Industry, Animal Feed Ingredient Market
    Forecast Analysis by End-Use Industry, Animal Feed Ingredient Market
    Unit Shipment Forecast by Region, Animal Feed Ingredient Market
    Key Mergers and Acquisitions - Animal Feed Ingredient Market, 2018-2020
    Unit Shipment Forecast by Region, Amino Acid
    Unit Shipment Forecast by Ingredients, Amino Acid
    Revenue Forecast by End-Use Industry, Amino Acid
    Unit Shipment Forecast by End-Use Industry, Amino Acid
    Forecast Analysis by End-Use Industry, Amino Acid
    Product Launches - Amino Acid, 2018-2019
    Patent/Technological Updates - Amino Acid, 2019 and 2020

Signing of Memorandum of Understanding regarding CCS Joint Study for Clean Fuel Ammonia Production in Indonesia

Retrieved on: 
金曜日, 3月 19, 2021
Chemistry, Physical sciences, Chemical compounds, Industrial gases, Household chemicals, Nitrogen cycle, Ammonia, Chemical industry, Fertilizer

The four parties have signed a Memorandum of Understanding (MOU).

Key Points: 
  • The four parties have signed a Memorandum of Understanding (MOU).
  • Ammonia is being used worldwide as raw material for fertilizers/plastics/chemicals.
  • Mitsubishi Gas Chemical Company, Inc., which also indirectly invests in PAU together with Mitsubishi Corporation, has expressed its interests to cooperate in this joint study.
  • Through this joint study, we will make effort to contribute towards realizing a decarbonized society and securing stable energy supply for Japan by pursuing the feasibility of clean fuel ammonia production from utilization of existing ammonia plant and CCS treatment of carbon dioxide generated during the production phase.

Global Acetaldehyde Ammonia (CAS 75-39-8) Market Report 2021: Trends and Developments, Major Players, Main Downstream Sectors, Market Prices - ResearchAndMarkets.com

Retrieved on: 
水曜日, 3月 17, 2021
Chemicals, Plastics, Manufacturing, Chemical compounds, Chemical substances, Chemistry, Refrigerants, Ammonia, Nitrogen cycle, Acetaldehyde, Market research

The "Acetaldehyde ammonia (CAS 75-39-8) Global Market Research Report 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Acetaldehyde ammonia (CAS 75-39-8) Global Market Research Report 2021" report has been added to ResearchAndMarkets.com's offering.
  • This global report is a result of industry experts' diligent work on researching the world market of Acetaldehyde ammonia.
  • The report helps to build up a clear view of the market trends and development, identify major players in the industry, and estimate main downstream sectors.
  • The fifth chapter deals with Acetaldehyde ammonia market trends and forecast, distinguish Acetaldehyde ammonia manufacturers and suppliers.

Fortescue and EIG-Backed Companies Sign MoU to Explore Joint Development of Green Hydrogen Plant in Brazil

Retrieved on: 
火曜日, 3月 16, 2021
Manufacturing, Professional services, Maritime, Other Energy, Transport, Oil, Gas, Steel, Alternative energy, Energy, Finance, Chemicals, Plastics, Articles, Sustainable technologies, Energy, Resource economics, Emerging technologies, Energy economics, Ammonia, Nitrogen cycle, Hydrogen vehicle, Low-carbon economy, Renewable energy, Port of Açu, Prumo Logística, EIG

The MoU also lays the groundwork for onsite solar power and offshore wind development projects in the states of Rio de Janeiro and Espirito Santo.

Key Points: 
  • The MoU also lays the groundwork for onsite solar power and offshore wind development projects in the states of Rio de Janeiro and Espirito Santo.
  • The proposed green hydrogen plant would have 300 megawatts of capacity with potential to produce 250,000 metric tons of green ammonia.
  • The availability of green hydrogen and renewable power is expected to drive further sustainable industrialization at the Port, including production of green steel, fertilizers, chemicals, fuels, and other sustainably manufactured industrial products.
  • If the project moves forward, it will accelerate the decarbonization of hard-to-abate sectors such as transportation, manufacturing, and heavy industry.

New Publication Explores Hidden Costs of Tank-Based Inhaled Nitric Oxide Delivery Systems

Retrieved on: 
木曜日, 3月 11, 2021
Chemistry, Physical sciences, Chemical compounds, Oxides, Gaseous signaling molecules, Nitrogen cycle, GABAA receptor positive allosteric modulators, NMDA receptor antagonists, Nitric oxide, Lead(II,IV) oxide, Nitric oxide, Biological functions of nitric oxide

Nitric oxide is a powerful molecule proven to play a critical role in a broad array of biological functions.

Key Points: 
  • Nitric oxide is a powerful molecule proven to play a critical role in a broad array of biological functions.
  • Methemoglobin levels in the blood increase with the dose of nitric oxide; following discontinuation or reduction of nitric oxide, methemoglobin levels return to baseline over a period of hours.
  • This proprietary delivery system eliminates the need for large nitric oxide tanks and the associated logistical burden.
  • VERO Biotech LLC is dedicated to improving the lives of patients by leading the development of innovative technologies for inhaled nitric oxide delivery in the acute care hospital setting and beyond, wherever inhaled nitric oxide treatment is needed.

Claritas Announces Formation of Nitric Oxide Scientific Advisory Board

Retrieved on: 
月曜日, 3月 8, 2021
Nitrogen cycle, Branches of biology, Chemistry, Physical sciences, Nitrogen compounds, Gaseous signaling molecules, Oxides, Nitric oxide, Endothelium-derived relaxing factor, Biological functions of nitric oxide

A synthetic chemist by training, Dr. Southan has an extensive experience and publication record in nitric oxide synthase (NOS) and in the chemistry of NOS inhibitors, nitric oxide adducts, and nitric oxide donor compounds.

Key Points: 
  • A synthetic chemist by training, Dr. Southan has an extensive experience and publication record in nitric oxide synthase (NOS) and in the chemistry of NOS inhibitors, nitric oxide adducts, and nitric oxide donor compounds.
  • In the course of these studies, he showed that EDRF is in fact nitric oxide, and, subsequently, that nitric oxide associated with these hydroxyguanidine compounds to stabilize its activity.
  • Using 15N labeled substrates and high-resolution mass-spectrometry, he was able to confirm that nitric oxide synthase utilizes the hydroxylated guanidino nitrogen of N-hydroxyarginine for the generation of nitric oxide.
  • At the same time, he discovered novel classes of inhibitors of nitric oxide synthase and nitric oxide generation, which had beneficial effects in models of inflammation and ischemic/reperfusion disease.

Claritas (formerly Kalytera Therapeutics) Announces Additional Program to Reduce the Rate and Spread of COVID-19 with Prophylactic R-107 Nasal Spray Designed to Provide Sustained Release of Nitric Oxide in the Nasal Cavities

Retrieved on: 
木曜日, 3月 4, 2021
Branches of biology, Medicine, Health sciences, Gaseous signaling molecules, Nitrogen cycle, Nitric oxide, Virus, Nitric oxide, Nasal spray, Biological functions of nitric oxide

The additional program that the Company is announcing today will develop R-107 as a nasal spray designed to be used prophylactically to prevent viral infections.

Key Points: 
  • The additional program that the Company is announcing today will develop R-107 as a nasal spray designed to be used prophylactically to prevent viral infections.
  • Hundreds of peer reviewed publications have documented that naturally occurring nitric oxide in the nasal cavities is a primary defense against invading viruses.
  • The R-107 nasal spray that Claritas is developing is designed to increase the level of nitric oxide present in the nasal cavities to kill the invading viruses, thereby reducing the rate, severity and spread of viral infections.
  • Professor Cuzzocrea has significant expertise regarding the medical use of nitric oxide and nitric oxide donors, and has published more than 600 peer reviewed papers on nitric oxide.

Claritas (formerly Kalytera Therapeutics, Inc.) to Collaborate with Salzman Group and Other Companies to Accelerate Development of R-107 for Treatment of Vaccine-Resistant COVID-19, Influenza, and Other Viral Infections

Retrieved on: 
水曜日, 3月 3, 2021
Chemistry, Physical sciences, Branches of biology, Gaseous signaling molecules, Nitrogen cycle, GABAA receptor positive allosteric modulators, NMDA receptor antagonists, Nitric oxide, Nitric oxide, Oxide

Under the Collaboration Agreement, Salzman Group will make available to Claritas the full capabilities of Salzman Group, including its expertise in working with nitric oxide and nitric oxide releasing compounds.

Key Points: 
  • Under the Collaboration Agreement, Salzman Group will make available to Claritas the full capabilities of Salzman Group, including its expertise in working with nitric oxide and nitric oxide releasing compounds.
  • Dr. Salzman received his undergraduate degree from Yale University and his medical degree from Harvard Medical School.
  • Dr. Salzman has taken 12 of his pharmaceutical inventions from the bench into the clinic.
  • Dr. Jagtap has over 50 patents co-invented with Dr. Salzman, and has co-developed over 8 small molecules with him over his career.